121 related articles for article (PubMed ID: 8789787)
1. Protection of organophosphate-inactivated esterases with phosphotriesterase.
Tuovinen K; Kaliste-Korhonen E; Raushel FM; Hänninen O
Fundam Appl Toxicol; 1996 Jun; 31(2):210-7. PubMed ID: 8789787
[TBL] [Abstract][Full Text] [Related]
2. Phosphotriesterase--a promising candidate for use in detoxification of organophosphates.
Tuovinen K; Kaliste-Korhonen E; Raushel FM; Hänninen O
Fundam Appl Toxicol; 1994 Nov; 23(4):578-84. PubMed ID: 7867909
[TBL] [Abstract][Full Text] [Related]
3. Phosphotriesterase, pralidoxime-2-chloride (2-PAM) and eptastigmine treatments and their combinations in DFP intoxication.
Tuovinen K; Kaliste-Korhonen E; Raushel FM; Hänninen O
Toxicol Appl Pharmacol; 1996 Dec; 141(2):555-60. PubMed ID: 8975781
[TBL] [Abstract][Full Text] [Related]
4. A theoretical model of the competition between hydrolase and carboxylesterase in protection against organophosphorus poisoning.
Sweeney RE; Maxwell DM
Math Biosci; 1999 Sep; 160(2):175-90. PubMed ID: 10472753
[TBL] [Abstract][Full Text] [Related]
5. Gender differences in activities of mouse esterase and sensitivities to DFP and sarin toxicity.
Tuovinen K; Kaliste-Korhonen E; Hänninen O
Gen Pharmacol; 1997 Sep; 29(3):333-5. PubMed ID: 9378236
[TBL] [Abstract][Full Text] [Related]
6. Long circulating liposomes encapsulating organophosphorus acid anhydrolase in diisopropylfluorophosphate antagonism.
Petrikovics I; Cheng TC; Papahadjopoulos D; Hong K; Yin R; DeFrank JJ; Jaing J; Song ZH; McGuinn WD; Sylvester D; Pei L; Madec J; Tamulinas C; Jaszberenyi JC; Barcza T; Way JL
Toxicol Sci; 2000 Sep; 57(1):16-21. PubMed ID: 10966507
[TBL] [Abstract][Full Text] [Related]
7. Role of carboxylesterase in soman, sarin and tabun poisoning in rats.
Jokanović M
Pharmacol Toxicol; 1989 Sep; 65(3):181-4. PubMed ID: 2813290
[TBL] [Abstract][Full Text] [Related]
8. Phosphotriesterase decreases paraoxon toxicity in mice.
Kaliste-Korhonen E; Ylitalo P; Hänninen O; Raushel FM
Toxicol Appl Pharmacol; 1993 Aug; 121(2):275-8. PubMed ID: 8394035
[TBL] [Abstract][Full Text] [Related]
9. An assessment of comparative acute toxicity of diisopropyl-fluorophosphate, tabun, sarin, and soman in relation to cholinergic and GABAergic enzyme activities in rats.
Sivam SP; Hoskins B; Ho IK
Fundam Appl Toxicol; 1984 Aug; 4(4):531-8. PubMed ID: 6479498
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the effects of diisopropylfluorophosphate, sarin, soman, and tabun on toxicity and brain acetylcholinesterase activity in mice.
Tripathi HL; Dewey WL
J Toxicol Environ Health; 1989; 26(4):437-46. PubMed ID: 2709438
[TBL] [Abstract][Full Text] [Related]
11. Interspecies differences in enzymes reacting with organophosphates and their inhibition by paraoxon in vitro.
Kaliste-Korhonen E; Tuovinen K; Hänninen O
Hum Exp Toxicol; 1996 Dec; 15(12):972-8. PubMed ID: 8981101
[TBL] [Abstract][Full Text] [Related]
12. Eptastigmine-phosphotriesterase combination in DFP intoxication.
Tuovinen K; Kaliste-Korhonen E; Raushel FM; Hänninen O
Toxicol Appl Pharmacol; 1996 Oct; 140(2):364-9. PubMed ID: 8887453
[TBL] [Abstract][Full Text] [Related]
13. Success of pyridostigmine, physostigmine, eptastigmine and phosphotriesterase treatments in acute sarin intoxication.
Tuovinen K; Kaliste-Korhonen E; Raushel FM; Hänninen O
Toxicology; 1999 Jun; 134(2-3):169-78. PubMed ID: 10403635
[TBL] [Abstract][Full Text] [Related]
14. Protection of mice against soman by pretreatment with eptastigmine and physostigmine.
Tuovinen K; Hänninen O
Toxicology; 1999 Dec; 139(3):233-41. PubMed ID: 10647923
[TBL] [Abstract][Full Text] [Related]
15. Elevated choline levels in brain. A non-cholinergic component of organophosphate toxicity.
Flynn CJ; Wecker L
Biochem Pharmacol; 1986 Sep; 35(18):3115-21. PubMed ID: 3753519
[TBL] [Abstract][Full Text] [Related]
16. Physostigmine (alone and together with adjunct) pretreatment against soman, sarin, tabun and VX intoxication.
Harris LW; Talbot BG; Lennox WJ; Anderson DR; Solana RP
Drug Chem Toxicol; 1991; 14(3):265-81. PubMed ID: 1935706
[TBL] [Abstract][Full Text] [Related]
17. Studies on low dose sub-acute administration of soman, sarin and tabun in the rat.
Dulaney MD; Hoskins B; Ho IK
Acta Pharmacol Toxicol (Copenh); 1985 Oct; 57(4):234-41. PubMed ID: 4083033
[TBL] [Abstract][Full Text] [Related]
18. Neuropathy target esterase in hens after sarin and soman.
Crowell JA; Parker RM; Bucci TJ; Dacre JC
J Biochem Toxicol; 1989; 4(1):15-20. PubMed ID: 2769693
[TBL] [Abstract][Full Text] [Related]
19. Variability of neurotoxicity of and lack of tolerance to the anticholinesterases soman and sarin in the rat.
Fernando JC; Lim DK; Hoskins B; Ho IK
Res Commun Chem Pathol Pharmacol; 1985 Jun; 48(3):415-30. PubMed ID: 4023423
[TBL] [Abstract][Full Text] [Related]
20. The specificity of carboxylesterase protection against the toxicity of organophosphorus compounds.
Maxwell DM
Toxicol Appl Pharmacol; 1992 Jun; 114(2):306-12. PubMed ID: 1609424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
